Onconetix, Inc. ONCO
1.03
0.12
13.19%
as of 25 Sep
- Market cap
- $4.6M
- P/E
- 0.0×
Follow ONCO
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(229.05%) | (127.79%) | (127.45%) | (105.23%) | |
| (124.62%) | (58.49%) | (59.69%) | (57.37%) | ||
ROIC |
(1,126.14%) | (105.85%) | (120.73%) | (135.42%) | |
Return on Tangible Assets |
339.86% | 512.23% | (774.32%) | (283.02%) | |
Average Days of Receivables |
0.78 | 155.28 | 21.69 | 1.36 | |
Free Cash Flow per Share |
(267.10) | (514.81) | (155.81) | (4.60) | |
Free Cash Flow |
(7.51) | (9.68) | (9.80) | (10.31) | |
Piotroski F-Score |
5.00 | 4.00 | 5.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(178.25%) | (46.12%) | (63.38%) | (53.10%) | |
Accounts Receivable Turnover |
24.33 | 4.38 | 24.51 | 88.48 | |
Accounts Payable Turnover |
0.06 | 0.07 | 0.07 | 0.06 | |
Inventory Turnover |
1.31 | 1.70 | 1.02 | 0.70 | |
Average Days of Payables |
3,687.19 | 3,515.40 | 3,735.04 | 5,319.02 | |
Days of Inventory on Hand |
309.82 | 300.00 | 335.27 | 606.60 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
(7.41%) | (8.11%) | (5.41%) | 11.66% | |
Selling, General and Administrative Expense of Revenue |
667.71% | 863.86% | 1,007.62% | 1,258.88% | |
Share Based Compensation of Revenue |
33.54% | 9.11% | 9.15% | 6.78% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.15 | 0.62 | 0.98 | 1.01 | |
Depreciation/Fixed assets |
269.86 | 3.75 | 4.29 | 4.67 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
43.55 | 43.37 | 11.69 | 0.29 | |
Operating CF per Share |
(267.10) | (514.81) | (155.81) | (4.60) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(4,154.71%) | (1,904.70%) | (1,364.04%) | (1,578.60%) |
Columns are period end dates